Holdings of Select Biotechnology Portfolio
Fidelity Select Portfolios · 161 declared positions · as of Feb 28, 2026
Original filing · Net assets 5.4B $ · Ten largest lines: 55.1 % of the equity sleeve
Country breakdown
Shares computed on the equity sleeve, the only part this site carries.
| Country | Lines | Value (USD) | Share |
|---|---|---|---|
| US | 135 | 4.6B $ | 87.48 % |
| DK | 3 | 173.2M $ | 3.29 % |
| NL | 4 | 148.8M $ | 2.83 % |
| BE | 1 | 116.3M $ | 2.21 % |
| BM | 1 | 57.1M $ | 1.09 % |
| CH | 2 | 45.9M $ | 0.87 % |
| FR | 2 | 44.4M $ | 0.84 % |
| VG | 1 | 18.5M $ | 0.35 % |
| CA | 2 | 15.2M $ | 0.29 % |
| IE | 3 | 11.8M $ | 0.22 % |
| DE | 1 | 9.4M $ | 0.18 % |
| SG | 1 | 6.8M $ | 0.13 % |
Sector breakdown is published in no regulatory filing: neither Form N-PORT nor the LEI reference data carries an activity code. It is absent rather than estimated.
Positions
| Company | Shares | Value (USD) | Weight |
|---|---|---|---|
| AbbVie Inc | 3,049,432 | 707.7M $ | 13.22 % |
| Krystal Biotech Inc | 1,806,522 | 497.9M $ | 9.30 % |
| Gilead Sciences Inc | 3,149,952 | 469.2M $ | 8.77 % |
| Amgen Inc | 1,149,551 | 446.2M $ | 8.34 % |
| Alnylam Pharmaceuticals Inc | 496,683 | 165.4M $ | 3.09 % |
| Praxis Precision Medicines Inc | 390,500 | 131.5M $ | 2.46 % |
| Ascendis Pharma A/S | 558,201 | 130.3M $ | 2.44 % |
| Insmed Inc | 811,101 | 121.1M $ | 2.26 % |
| UCB SA | 390,274 | 116.3M $ | 2.17 % |
| Argenx SE | 149,344 | 114.5M $ | 2.14 % |
| Regeneron Pharmaceuticals, Inc. | 101,316 | 79.2M $ | 1.48 % |
| Moderna Inc | 1,432,529 | 76.7M $ | 1.43 % |
| Scholar Rock Holding Corp | 1,650,449 | 73.1M $ | 1.37 % |
| Natera Inc | 331,532 | 69M $ | 1.29 % |
| Cogent Biosciences Inc | 1,691,394 | 65.7M $ | 1.23 % |
| CENTESSA PHARMACEUTICALS PLC | 2,187,494 | 58.8M $ | 1.10 % |
| Biogen Inc | 299,435 | 57.4M $ | 1.07 % |
| Roivant Sciences Ltd | 1,972,719 | 57.1M $ | 1.07 % |
| Vertex Pharmaceuticals Inc | 112,900 | 56.1M $ | 1.05 % |
| Bridgebio Pharma Inc | 707,304 | 47M $ | 0.88 % |
| Protagonist Therapeutics Inc | 506,713 | 46.7M $ | 0.87 % |
| Immunome Inc | 2,131,664 | 46.6M $ | 0.87 % |
| Terns Pharmaceuticals Inc | 1,079,186 | 45.5M $ | 0.85 % |
| Revolution Medicines Inc | 438,772 | 44.8M $ | 0.84 % |
| Kymera Therapeutics Inc | 462,441 | 42.2M $ | 0.79 % |
| Ionis Pharmaceuticals Inc | 476,377 | 38.7M $ | 0.72 % |
| ArriVent Biopharma Inc | 1,680,003 | 38.6M $ | 0.72 % |
| Crinetics Pharmaceuticals Inc | 926,671 | 38.1M $ | 0.71 % |
| Abivax SA | 301,600 | 36.6M $ | 0.68 % |
| Structure Therapeutics Inc | 564,438 | 35.5M $ | 0.66 % |
| Disc Medicine Inc | 532,174 | 35.5M $ | 0.66 % |
| Galderma Group AG | 184,660 | 34.8M $ | 0.65 % |
| Zealand Pharma A/S | 589,130 | 33.9M $ | 0.63 % |
| Cytokinetics Inc | 503,175 | 31.3M $ | 0.59 % |
| Candel Therapeutics Inc | 5,911,951 | 31M $ | 0.58 % |
| Viridian Therapeutics Inc | 1,001,204 | 29.4M $ | 0.55 % |
| Vaxcyte Inc | 470,455 | 29M $ | 0.54 % |
| Stoke Therapeutics Inc | 792,594 | 28.9M $ | 0.54 % |
| Nuvalent Inc | 273,399 | 27.9M $ | 0.52 % |
| Apogee Therapeutics Inc | 392,757 | 27.5M $ | 0.51 % |
| Trevi Therapeutics Inc | 2,288,485 | 27.3M $ | 0.51 % |
| Annexon Inc | 4,733,596 | 26.5M $ | 0.50 % |
| Arrowhead Pharmaceuticals Inc | 409,378 | 25.9M $ | 0.48 % |
| Dianthus Therapeutics Inc | 432,218 | 23.9M $ | 0.45 % |
| Vor BioPharma Inc | 1,536,125 | 23.7M $ | 0.44 % |
| Edgewise Therapeutics Inc | 776,925 | 23.6M $ | 0.44 % |
| United Therapeutics Corp | 44,593 | 22.5M $ | 0.42 % |
| Intellia Therapeutics Inc | 1,607,833 | 22.2M $ | 0.41 % |
| Travere Therapeutics Inc | 720,343 | 21.5M $ | 0.40 % |
| Dyne Therapeutics Inc | 1,368,144 | 21.4M $ | 0.40 % |
| Corcept Therapeutics Inc | 575,646 | 20.6M $ | 0.38 % |
| Ideaya Biosciences Inc | 637,957 | 20.5M $ | 0.38 % |
| Madrigal Pharmaceuticals Inc | 47,495 | 20.5M $ | 0.38 % |
| Newamsterdam Pharma Co NV | 562,500 | 19.9M $ | 0.37 % |
| Amylyx Pharmaceuticals Inc | 1,219,575 | 18.5M $ | 0.35 % |
| Biohaven Ltd | 1,603,096 | 18.5M $ | 0.35 % |
| Summit Therapeutics Inc | 1,089,169 | 18.1M $ | 0.34 % |
| Spyre Therapeutics Inc | 401,953 | 17.3M $ | 0.32 % |
| Arcus Biosciences Inc | 831,100 | 16.9M $ | 0.32 % |
| Olema Pharmaceuticals Inc | 693,100 | 16.8M $ | 0.31 % |
| Alumis Inc | 561,900 | 16.7M $ | 0.31 % |
| Oruka Therapeutics Inc | 475,783 | 16.4M $ | 0.31 % |
| Bicara Therapeutics Inc | 944,900 | 15.9M $ | 0.30 % |
| Axsome Therapeutics Inc | 92,303 | 15.1M $ | 0.28 % |
| Replimune Group Inc | 1,864,545 | 14.3M $ | 0.27 % |
| Maze Therapeutics Inc | 311,885 | 14.2M $ | 0.27 % |
| Rapport Therapeutics Inc | 471,773 | 13.7M $ | 0.26 % |
| Viking Therapeutics Inc | 404,257 | 13.7M $ | 0.26 % |
| DAMORA THERAPEUTICS INC | 454,559 | 13.4M $ | 0.25 % |
| BEONE MEDICINES LTD | 41,698 | 13.2M $ | 0.25 % |
| Xenon Pharmaceuticals Inc | 297,364 | 12.9M $ | 0.24 % |
| Nuvation Bio Inc | 2,164,933 | 12.8M $ | 0.24 % |
| Mineralys Therapeutics Inc | 421,700 | 12.3M $ | 0.23 % |
| Kiniksa Pharmaceuticals International Plc | 267,500 | 11.9M $ | 0.22 % |
| Solid Biosciences Inc | 1,791,160 | 11.1M $ | 0.21 % |
| Idorsia Ltd | 2,174,283 | 11.1M $ | 0.21 % |
| Geron Corp | 6,492,512 | 10.9M $ | 0.20 % |
| Enliven Therapeutics Inc | 363,267 | 10.8M $ | 0.20 % |
| Tectonic Therapeutic Inc | 442,889 | 10.4M $ | 0.19 % |
| Immunocore Holdings PLC | 321,500 | 10.4M $ | 0.19 % |
| uniQure NV | 650,282 | 10.2M $ | 0.19 % |
| ZENAS BIOPHARMA INC | 380,400 | 10M $ | 0.19 % |
| VTV THERAPEUTICS INC | 260,391 | 9.9M $ | 0.19 % |
| BioNTech SE | 85,400 | 9.4M $ | 0.18 % |
| Forte Biosciences Inc | 310,965 | 9.4M $ | 0.18 % |
| Rhythm Pharmaceuticals Inc | 99,803 | 9.3M $ | 0.17 % |
| PTC Therapeutics Inc | 134,511 | 9.2M $ | 0.17 % |
| Gubra A/S | 145,554 | 9M $ | 0.17 % |
| Capricor Therapeutics Inc | 314,700 | 8.8M $ | 0.16 % |
| Twist Bioscience Corp | 170,825 | 8M $ | 0.15 % |
| SENSORION SA | 18,153,474 | 7.8M $ | 0.15 % |
| Aktis Oncology Inc | 383,955 | 7.7M $ | 0.14 % |
| MannKind Corp | 2,185,101 | 7.2M $ | 0.13 % |
| Ocular Therapeutix Inc | 784,000 | 7M $ | 0.13 % |
| Beam Therapeutics Inc | 244,914 | 7M $ | 0.13 % |
| Immunovant Inc | 250,021 | 6.9M $ | 0.13 % |
| WaVe Life Sciences Ltd | 487,140 | 6.8M $ | 0.13 % |
| CytomX Therapeutics Inc | 1,222,540 | 6.6M $ | 0.12 % |
| Tango Therapeutics Inc | 586,000 | 6.5M $ | 0.12 % |
| Immuneering Corp | 1,290,698 | 6.4M $ | 0.12 % |
| Design Therapeutics Inc | 616,831 | 6.4M $ | 0.12 % |
| Nurix Therapeutics Inc | 396,646 | 6.3M $ | 0.12 % |
| CAMP4 THERAPEUTICS CORP | 1,326,208 | 6M $ | 0.11 % |
| X4 PHARMACEUTICALS INC | 1,685,700 | 5.8M $ | 0.11 % |
| Prothena Corp PLC | 643,917 | 5.6M $ | 0.10 % |
| Alector Inc | 2,221,104 | 5.4M $ | 0.10 % |
| LB Pharmaceuticals Inc | 221,731 | 5.3M $ | 0.10 % |
| Sana Biotechnology Inc | 1,263,152 | 5.3M $ | 0.10 % |
| Jazz Pharmaceuticals PLC | 25,600 | 4.9M $ | 0.09 % |
| JADE BIOSCIENCES INC | 321,707 | 4.8M $ | 0.09 % |
| Vera Therapeutics Inc | 109,013 | 4.4M $ | 0.08 % |
| Hansa Biopharma AB | 1,176,800 | 4.4M $ | 0.08 % |
| Denali Therapeutics Inc | 205,263 | 4.3M $ | 0.08 % |
| Taysha Gene Therapies Inc | 940,476 | 4.3M $ | 0.08 % |
| Absci Corp | 1,540,796 | 4.2M $ | 0.08 % |
| Eikon Therapeutics Inc | 305,088 | 4.2M $ | 0.08 % |
| Pharvaris NV | 147,914 | 4.2M $ | 0.08 % |
| Allogene Therapeutics Inc | 1,401,115 | 3.9M $ | 0.07 % |
| Foghorn Therapeutics Inc | 654,278 | 3.7M $ | 0.07 % |
| Soleno Therapeutics Inc | 87,300 | 3.4M $ | 0.06 % |
| Zura Bio Ltd | 509,657 | 3.4M $ | 0.06 % |
| ARS Pharmaceuticals Inc | 335,156 | 3.1M $ | 0.06 % |
| Janux Therapeutics Inc | 206,670 | 2.8M $ | 0.05 % |
| Cartesian Therapeutics Inc | 366,554 | 2.8M $ | 0.05 % |
| MoonLake Immunotherapeutics | 143,558 | 2.5M $ | 0.05 % |
| BridgeBio Oncology Therapeutics Inc | 240,300 | 2.4M $ | 0.05 % |
| ENGENE HOLDINGS INC | 232,200 | 2.3M $ | 0.04 % |
| Palvella Therapeutics Inc | 16,700 | 2.3M $ | 0.04 % |
| TG Therapeutics Inc | 66,231 | 2M $ | 0.04 % |
| Mirum Pharmaceuticals Inc | 20,400 | 1.9M $ | 0.04 % |
| Upstream Bio Inc | 234,657 | 1.8M $ | 0.03 % |
| Exelixis Inc | 40,610 | 1.8M $ | 0.03 % |
| aTyr Pharma Inc | 1,754,594 | 1.7M $ | 0.03 % |
| CARTESIAN THERAPEUTICS INC | 5,385,728 | 1.6M $ | 0.03 % |
| Shattuck Labs Inc | 391,662 | 1.5M $ | 0.03 % |
| Perspective Therapeutics Inc | 258,600 | 1.4M $ | 0.03 % |
| GH RESEARCH PLC | 92,500 | 1.4M $ | 0.03 % |
| CRESCENT BIOPHARMA INC | 113,421 | 1.4M $ | 0.03 % |
| CG oncology Inc | 22,628 | 1.3M $ | 0.02 % |
| AnaptysBio Inc | 23,300 | 1.3M $ | 0.02 % |
| Neurogene Inc | 51,100 | 1.2M $ | 0.02 % |
| Day One Biopharmaceuticals Inc | 108,347 | 1.1M $ | 0.02 % |
| Atea Pharmaceuticals Inc | 237,534 | 1.1M $ | 0.02 % |
| VeraDermics Inc | 20,800 | 953.7K $ | 0.02 % |
| LEXICON PHARMACEUTICALS INC | 515,300 | 757.5K $ | 0.01 % |
| LEGEND BIOTECH CORP | 32,710 | 621.5K $ | 0.01 % |
| BIOMEA FUSION INC | 452,663 | 620.1K $ | 0.01 % |
| Erasca Inc | 39,880 | 544.8K $ | 0.01 % |
| LENZ Therapeutics Inc | 38,058 | 513.4K $ | 0.01 % |
| Harmony Biosciences Holdings Inc | 17,525 | 500.2K $ | 0.01 % |
| Apellis Pharmaceuticals Inc | 23,822 | 499.3K $ | 0.01 % |
| Tarsus Pharmaceuticals Inc | 4,800 | 362.5K $ | 0.01 % |
| Keros Therapeutics Inc | 24,578 | 348.8K $ | 0.01 % |
| BioCryst Pharmaceuticals Inc | 37,881 | 331.5K $ | 0.01 % |
| Entrada Therapeutics Inc | 14,169 | 169K $ | 0.00 % |
| Novocure Ltd | 11,113 | 151.9K $ | 0.00 % |
| BIOXCEL THERAPEUTICS INC | 90,300 | 150.8K $ | 0.00 % |
| Inhibikase Therapeutics Inc | 56,270 | 115.4K $ | 0.00 % |
| Ultragenyx Pharmaceutical Inc | 3,489 | 81.6K $ | 0.00 % |
| OPTINOSE INC | 91,712 | 0.9 $ | |
| AXCELLA HEALTH INC | 66,454 | 0.7 $ |